IRIS
CASSANO, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.514
EU - Europa 3.814
AS - Asia 3.292
SA - Sud America 446
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 12.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.439
SG - Singapore 1.122
CN - Cina 1.120
IE - Irlanda 941
UA - Ucraina 635
RU - Federazione Russa 552
SE - Svezia 436
IT - Italia 385
BR - Brasile 367
HK - Hong Kong 294
FR - Francia 273
DE - Germania 226
VN - Vietnam 196
IN - India 191
FI - Finlandia 129
TR - Turchia 123
KR - Corea 80
GB - Regno Unito 79
AT - Austria 44
CA - Canada 28
MX - Messico 25
AR - Argentina 22
ID - Indonesia 22
BD - Bangladesh 21
NL - Olanda 20
IQ - Iraq 19
PL - Polonia 19
JP - Giappone 17
ZA - Sudafrica 17
BE - Belgio 16
EC - Ecuador 13
MA - Marocco 13
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
CL - Cile 9
CO - Colombia 9
EU - Europa 8
LT - Lituania 8
PK - Pakistan 8
PY - Paraguay 8
SA - Arabia Saudita 8
VE - Venezuela 8
CH - Svizzera 6
ES - Italia 6
BH - Bahrain 5
CR - Costa Rica 5
KE - Kenya 5
TN - Tunisia 5
DK - Danimarca 4
DZ - Algeria 4
HN - Honduras 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
TH - Thailandia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SN - Senegal 3
BO - Bolivia 2
NI - Nicaragua 2
NO - Norvegia 2
RO - Romania 2
TV - Tuvalu 2
AL - Albania 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 12.133
Salva come PNG Salva come JPEG
Città #
Dublin 939
San Jose 611
Singapore 603
Chandler 536
Jacksonville 428
Dearborn 325
Ashburn 306
Hong Kong 293
Nyköping 291
Beijing 263
Nanjing 205
Dallas 192
Santa Clara 134
Lauterbourg 104
Wilmington 104
Princeton 98
New York 87
The Dalles 84
Nanchang 71
Ann Arbor 70
Moscow 63
San Mateo 63
Ho Chi Minh City 60
Helsinki 56
Los Angeles 51
Des Moines 49
Boardman 48
Rome 48
Shenyang 47
Munich 45
Hebei 44
Tianjin 39
Hilden 36
Hanoi 35
Woodbridge 33
Jiaxing 32
Foggia 30
Kunming 30
São Paulo 30
Vienna 30
Pune 29
Hangzhou 28
Jinan 28
Guangzhou 27
Council Bluffs 23
Bari 22
Seattle 19
Changsha 18
Ningbo 17
Brussels 16
Warsaw 16
Columbus 15
Frankfurt am Main 15
Milan 15
Wuhan 15
Brooklyn 14
Zhengzhou 14
Chennai 13
Haiphong 13
Shanghai 13
Chicago 12
Dong Ket 12
Falls Church 12
Rio de Janeiro 12
San Severo 12
Tashkent 12
Tokyo 12
Atlanta 10
Düsseldorf 10
Jakarta 10
Lanzhou 10
Norwalk 10
San Francisco 10
Washington 10
Auburn Hills 9
Johannesburg 9
Orem 9
Toronto 9
West Jordan 9
Denver 8
Houston 8
Naples 8
New Delhi 8
Porto Alegre 8
Redwood City 8
Boston 7
Da Nang 7
Hefei 7
Nuremberg 7
Philadelphia 7
Santeramo In Colle 7
Stockholm 7
Amsterdam 6
Ankara 6
Baghdad 6
Biên Hòa 6
Curitiba 6
Dhaka 6
Falkenstein 6
Hillsboro 6
Totale 7.327
Salva come PNG Salva come JPEG
Nome #
Use of mammalian target of rapamycin inhibitor for treating pathologies including neurodegenerative diseases (Alzheimer's disease), neuroinflammatory diseases and tumor diseases with neurological involvement, by intrathecal administration 209
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in wistar rats. 169
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 163
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 156
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 156
Biochemical and Neurobehavioral Profile of CHF2819, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease 155
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 153
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 149
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 149
Antinutritional effects of fumonisin B1 and pathophysiological consequences 148
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 146
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 145
Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels 144
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 143
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 141
Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects 141
Aberrant insulin signaling in Alzheimer's disease: current knowledge 139
Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. 138
Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration 138
Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats 137
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex 136
Novel codrugs with GABAergic activity for dopamine delivery in the brain 136
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 134
Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target 134
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease 133
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles 132
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 130
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 130
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 128
Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. 127
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder 126
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons 126
CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor 125
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 124
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 123
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 123
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease 123
Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring 122
Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring 122
Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor 122
Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice 122
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 120
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease: In Vitro and In Vivo Evidence 120
Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence [Biomed. Pharmacother. 188 (2025) 118199] 119
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 118
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs 117
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 116
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress 115
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. 114
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 114
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress 112
Olfactory memory is impaired in a triple transgenic model of Alzheimer disease 111
Astrocyte function is affected by aging and not Alzheimer's disease: A preliminary investigation in hippocampi of 3xTg-AD mice 111
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm 110
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 109
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 109
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures 107
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 107
Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients 107
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 105
Prenatal Exposure to the CB1 Receptor Agonist Win 55,212-2 Causes Learning Disruption Associated With Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring 105
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 105
Role of the area postrema in the hypophagic effects of oleoylethanolamide 105
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 104
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 103
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 103
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 103
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: An in vivo study 102
Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide 101
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard 100
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge-eating disorder 99
Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide 98
Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats 97
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin 97
Lung histopathological findings in COVID-19 disease - a systematic review 96
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 96
Editorial: Dysmetabolism, obesity, and inflammation: Three prominent actors in the drama of major neuropsychiatric disorders 96
Delta9-Tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons. Involvement of CB1 receptors 95
The effects of oleoylethanolamide on feeding behaviour involve hypothalamic oxytocin neurons 94
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 94
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease 93
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. 92
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 92
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 92
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 91
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease 90
The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: An in vivo microdialysis study in the awake rat 90
Neurochemical changes produced by CHF2819, a novel, orally active acetylcholinesterase inhibitor, in rat brain 89
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 89
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 87
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 86
Insulin signaling: An opportunistic target to minify risk of Alzheimer's disease 85
The Role of Toll-Like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 84
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus 83
Effects of ENA713 and CHF2819, two anti-Alzheimer’s disease drugs, on rat amino acid levels 81
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats 81
Compromised decision-making and increased gambling proneness following dietary serotonin depletion in rats 78
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 77
From obesity resistance to obesity prediction and prevention? 77
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice 76
Totale 11.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.065
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 131 1 16
2021/2022538 64 11 4 8 39 14 12 38 89 76 30 153
2022/20232.350 202 96 96 158 115 230 39 194 1.104 23 46 47
2023/2024472 61 32 17 23 46 157 21 11 2 11 2 89
2024/20251.916 85 19 79 64 72 234 231 95 468 151 213 205
2025/20263.576 246 304 510 511 259 153 761 405 282 145 0 0
Totale 12.570